These compounds may interact with:
Fibroblast growth factor receptor 3
Potentially involved in: ladd syndrome; muenke syndrome; hypochondroplasia; urinary bladder cancer; thanatophoric dysplasia; craniosynostosis; achondroplasia; multiple myeloma; doid:0050532; immune system cancer; lymphoid leukemia; papilloma; carcinoma; urinary system cancer; skin cancer; upper respiratory tract disease; acanthosis nigricans; acrocephalosyndactylia; cancer; bladder transitional cell papilloma
Disease data sourced from Pharos.